- We focus on the following health care areas: cardiovascular, diabetes, gastrointestinal, neuroscience, oncology, respiratory, rheumatology, anaesthesia and pain management.
- We have 57,200 employees worldwide, 31% are in the Americas, 46% in Europe, Middle East and Africa and 23% in Asia-Pacific.
- We are active in more than 100 countries with a growing presence in emerging markets such as China, Mexico, Brazil and Russia.
- In 2011 our sales totalled $33.6 billion.
- Around 11,300 people work in our R&D organisation and we have 14 principal R&D centres in eight countries.
- Globally, we invest $17 million per day in R&D, including 20 drug development projects for personalised health initiatives.
- We have 9,600 employees at 23 Supply and Manufacturing sites in 16 countries.